Glucose control and insulin resistance in non-insulin-dependent diabetes mellitus

Annals of Internal Medicine

Volumn 124, Issue 1 II, 1996, Pages 97-103

  Henry, Robert R ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; METFORMIN; SULFONYLUREA DERIVATIVE;

CLINICAL FEATURE; CONFERENCE PAPER; DIABETIC MICROANGIOPATHY; DIABETIC NEUROPATHY; DOSE RESPONSE; HUMAN; HYPERGLYCEMIA; HYPERINSULINEMIA; INSULIN INFUSION; INSULIN RESISTANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RISK FACTOR; SUBCUTANEOUS DRUG ADMINISTRATION; TREATMENT OUTCOME; TREATMENT PLANNING; WEIGHT GAIN; WEIGHT REDUCTION;

EID: 0030065633     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-124-1_part_2-199601011-00004     Document Type: Conference Paper

References (19)

1. Marrero DG. Current effectiveness of diabetes health care in the U.S How far from the idea? Diabetes Reviews 1994,2 292-309.
2. Reaven GM. Banting lecture 1988 Role of insulin resistance in human disease Diabetes 1988,37 1595-607.
3. Reichard P, Nilsson BY, Rosenqvist U. The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. N Engl J Med 1993,329 304-9
4. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus N Engl J Med 1993;329 977-86.
5. Bierman EL. George Lyman Duff Memorial Lecture Artherogenesis in diabetes Arterioscler Thromb. 1992; 12:647-56
6. Olefsky JM. Introduction: pathogenesis of insulin resistance and hyperglycemia in NIDDM Am J Med. 1985,79(Suppl 3B):1-7
7. American Diabetes Association. Medical Management of Non-Insulin-Dependent (Type II) Diabetes Third ed. Alexandria, Virginia: American Diabetes Association; 1994 26
8. American Diabetes Association. Physician's Guide to Non-Insulin-Dependent (Type II) Diabetes Diagnosis and Treatment Second ed. Alexandria, Virginia. American Diabetes Association, 1988.25
9. Henry RR, Wallace P, Olefsky JM. Effects of weight loss on mechanisms of hyperglycemia in obese non-insulin-dependent diabetes mellitus Diabetes 1986,35:990-8
10. Gerich JE. Oral hypoglycemic agents N Engl J Med 1989,321 1231-45
11. DeFronzo RA, Barzilai N, Simonson DC. Mechanism of metformin action in obese and lean noninsulin-dependent diabetic subjects J Clin Endocnnol Metab. 1991;73 1294-301
12. DeFronzo RA, Goodman AM, and the Multicenter Metformin Study Group. Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus N Engl J Med 1995,333.541-9
13. UK Prospective Diabetes Study (UKPDS). VIII Study design, progress and performance. UK Prospective Diabetes Study Group Diabetologia. 1991,34: 877-90
14. Garvey WT, Olefsky JM, Griffin J, Hamman RF, Kolterman OG. The effect of insulin treatment on insulin secretion and insulin action in type II diabetes mellitus. Diabetes. 1985,34.222-34
15. Henry RR, Gumbiner B, Ditzler T, Wallace P, Lyon R, Glauber HS. Intensive conventional insulin therapy for type II diabetes. Metabolic effects during a 6-mo outpatient trial Diabetes Care. 1993,16:21-31.
16. Yki-Jarvinen H, Kauppila M, Kujansuu E, Lahti J, Marjanen T, Niskanen L, et al. Comparison of insulin regimens in patients with non-insulin-dependent diabetes mellitus N Engl J Med 1992,327 1426-33.
17. Bloomgarden ZT. American Diabetes Association Scientific Sessions. 1995 Non-insulin-dependent diabetes mellitus Diabetes Care 1995,18.1215-9
18. Donnelly R, Morris AD. Drugs and insulin resistance: clinical methods of evaluation and new pharmacological approaches to metabolism Br J Clin Pharmacol 1994.37 311-20
19. Nolan JJ, Ludvik B, Beerdsen P, Joyce M, Olefsky J. Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone N Engl J Med 1994,331 1188-93